WÜRTEMBERGER, Urs, DIEBOLD, Martin, RAU, Alexander, AKGÜN, Veysel, BECKER, Lucas, BECK, Jürgen, REINACHER, Peter, TASCHNER, Christian, REISERT, Marco, FEHRENBACHER, Luca, ERNY, Daniel, SCHERER, Florian Paul, HOHENHAUS, Marc, URBACH, Horst und DEMERATH, Theo, 2024. Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma. Freiburg: Universität.
Elsevier - Harvard (with titles)Würtemberger, U., Diebold, M., Rau, A., Akgün, V., Becker, L., Beck, J., Reinacher, P., Taschner, C., Reisert, M., Fehrenbacher, L., Erny, D., Scherer, F.P., Hohenhaus, M., Urbach, H., Demerath, T., 2024. Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma. Universität, Freiburg. https://doi.org/10.1093/noajnl/vdae093
American Psychological Association 7th editionWürtemberger, U., Diebold, M., Rau, A., Akgün, V., Becker, L., Beck, J., Reinacher, P., Taschner, C., Reisert, M., Fehrenbacher, L., Erny, D., Scherer, F. P., Hohenhaus, M., Urbach, H., & Demerath, T. (ca. 2024). Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma [Cd]. Universität. https://doi.org/10.1093/noajnl/vdae093
Springer - Basic (author-date)Würtemberger U, Diebold M, Rau A, Akgün V, Becker L, Beck J, Reinacher P, Taschner C, Reisert M, Fehrenbacher L, Erny D, Scherer FP, Hohenhaus M, Urbach H, Demerath T (2024) Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Würtemberger, Urs/ Diebold, Martin/ Rau, Alexander/ Akgün, Veysel/ Becker, Lucas/ Beck, Jürgen/ Reinacher, Peter/ Taschner, Christian/ Reisert, Marco/ Fehrenbacher, Luca/ Erny, Daniel/ Scherer, Florian Paul/ Hohenhaus, Marc/ Urbach, Horst/ Demerath, Theo, Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma, Freiburg 2024.